Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02802111Completed
Randomised, single-blind trial of levalbuterol in asthma and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Children's Hospital Los Angeles. Primary endpoint: Oxygen Consumption. Started Jun 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02802111.